Lyophilized composition of bone morphogenetic factor human MP52
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 8, 2004
app pub date -
Sep 22, 2003
filing date -
Jan 30, 1997
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
By mixing bone morphogenetic factor human MP52 with mannitol at a weight ratio of 1:5-50, followed by lyophilization, a stable lyophilized composition of bone morphogenetic factor human MP52 is obtained which prevents coloring and atrophy of the lyophilized product of bone morphogenetic factor human MP52 during storage and also prevents cohesion at the time of reconstitution.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully